Cryptogenic Stroke Study

Long-Term Cardiac Monitoring for Detection of Atrial Fibrillation After Cryptogenic Stroke

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00861133

Enrollment

100

Registered

2009-03-13

Start date

2009-03-31

Completion date

2011-05-31

Last updated

2009-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cryptogenic Stroke

Keywords

cardiac monitor, loop recorder, stroke, ECG, Implantable Loop Recorder, cryptogenic, ILR

Brief summary

The purpose of this study is to determine whether the Sleuth Implantable Loop Recorder will enhance detection of latent atrial fibrillation in patients after cryptogenic stroke.

Interventions

DEVICESleuth AT Implantable ECG Monitoring System

The study device provides monitoring only. It cannot provide intervention or treatment.

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Recent stroke (within 30 days) as defined by who has a sudden onset of focal neurological deficits presumed vascular etiology and lasting more than 24 hours. * Negative brain image for hemorrhagic stroke * In sinus rhythm at time of enrollment

Exclusion criteria

* Know history of atrial fibrillation * Previous implanted cardiac device (ppM or ICD) * Serious illness making it unlikely to survive one year * Known secondary cause of stroke

Design outcomes

Primary

Measure	Time frame
Incidence of atrial fibrillation at one year from Sleuth implantation.	One Year

Countries

United States

Contacts

Primary ContactM Broich

mbroich@transomamedical.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026